Regastim gastro powder 90g

It has a reparative, anti-inflammatory and enveloping effect in inflammatory-dystrophic diseases of the gastric mucosa.
Stimulates regeneration processes in case of their suppression in the presence of foci of atrophy of the gastric mucosa, preventing a reduction in the number of gastric glands. It helps to normalize the pH of the stomach (due to an increase in the number of gastric secretion glands in the preserved areas of the gastric mucosa), reduce the level of gastrin-17 in the blood, increase the ratio of pepsinogen I / pepsinogen II levels, which is an indicator of the restoration of acid-forming and pepsin-forming functions and the weakening of pro-oncogenic processes associated with these disorders.
The drug has an anti-inflammatory effect, reducing the level of leukocyte infiltration of the gastric mucosa mainly due to eosinophilic granulocytes and macrophages.
It has a regulatory effect on the reactions of cellular, humoral immunity and non-specific resistance.
After eradication therapy (in people with Helicobacter pylori infection), treatment with the drug promotes a more pronounced decrease in the titer of anti-Helicobacter antibodies, reducing the activity of the autoimmune component of inflammation of the gastric mucosa.

Composition: per 1 g of powder
Active substance: alpha-glutamyl-tryptophan (Thymogen® sodium) (0.352 mg) in terms of alpha-glutamyl-tryptophan) 0.330 mg.
Excipients: sodium alginate, sodium carmellose, fructose, colloidal silicon dioxide.

Orally. The drug is taken orally in the form of a gel 2 times a day on an empty stomach (in the morning 20-30 minutes before meals and in the evening before bedtime, not earlier than an hour after meals). Before use, mix a single dose of 3 g of powder (1 teaspoon) for about 3-5 minutes in 50 ml (1/4 cup) of hot, but not boiling water until a gel of uniform consistency is obtained. Prepare the gel immediately before use. For ease of mixing, it is recommended to add water to the powder, and not vice versa.
The course of treatment is 28 days.
For atrophic gastritis associated with Helicobacter pylori, the drug is used after a course of eradication therapy.
If the treatment dynamics are positive, a repeat course may be administered after 2 weeks as prescribed by the doctor.